DR. SUMAYA AL-JANABI
Sumaya is a pharmacist who is very passionate in helping the growth of the Healthcare Industry in her home country, Iraq.
Driven by her ambition in providing the most innovative products, she always creates the right roadmap to secure the access and availability of medications to Iraqi patients. With more than 13 years of experience, Sumaya has mastered an outstanding skill in managing MoH tenders and finding alternative solutions, amid the most challenging situations. She believes that Agility and Adaptability are the secret recipe for success, especially in this part of the world.
When she is not working, you will find Sumaya swaying to the tunes of Latin music, which is another passion in her life.
DR. SUMAYA AL-JANABI
Head of Tenders & Market Access at Global Health – Iraq
PROF. ABDALLA ABOTALEB
Abdalla Aboutaleb is one of the most profound experts in healthcare policy and regulations in the MENA region. His expertise extends from HTA & Reimbursement policies to regulatory and supply chain strategies in the public sector. He has been involved in the fields of health economics, outcomes research, health policy reforming and
Reimbursement police within the healthcare industry for 15 years, with experience across the pharmaceutical, biologicals and vaccines. And now works for WHO as a project manager at health care reforming area. He, in addition to being a committee member and project manager in a number of national projects in many countries
including Germany. United Kingdom, Egypt, Algeria, Sudan, Russia, UAE, Morocco, Jordan, Iraq, Turkey, KSA, GULF, USA and Poland. He is a very active researcher with tens of publication across different well recognized organizing including ISPOR, ESMO, ASCO , ECCO, iHEA.
HTAI and EuHEA. He has been a true contributor to several public and industrial projects in Egypt and the MENA region of his homeland. He committedly changed the landscape of the healthcare policy there. A few examples to mention are his contributions to the establishment of the NORCB (national organization for control and research of biologics), Egyptian Biosimilars guidelines the
cancer and MS registry & guidelines. Establishing stroke units & guidelines, hospital based HTA and Health economic unit at the Ministry of Health in Egypt’s different sectors.
Multiple engagement efforts are well recognized in his research through introducing concepts of stakeholder engagement. He also does that by being an active member of many research organizations internationally and locally like the ISPOR and its local chapter. Abdalla Aboutaleb remains a very rich source of developmental initiatives having been hands on expert across different sectors of the healthcare systems and a visionary for healthcare reform.
PROF. ABDALLA ABOTALEB
Project Manager at World Health Organization (WHO)
Speakers 2023
MS. RANIA KASSAB
Procurement Director – TMEA at Stem Healthcare
DR. SOFYAN SALEH OQLAH MIGDADI
Head Of Pharmaceutical and Procurement Department at King Abdulla University Hospital – Jordan
MS. MARYAM AHMED SAYED MAHDI
Specialist Drugs Accreditation Drugs & Medical Products Division at the Department of Health (DOH)
FATIMA ALI KARJI AL MARZOOQI
She is a committed professional with exceptional administrative skills and operational experience who develops best practice and leads transformational change.
Significant exposure in working on strategic management, organizational development, conducting organizational assessments, performance management and process engineering/re-engineering.
Adopt at working under tight deadlines and delivering results under demanding work conditions. Efficient Team Leader & Player.
FATIMA ALI KARJI AL MARZOOQI
Senior Pharmacist – Pharmaceuticals & Medical Consumable Purchasing Section at Emirates Health Services
DR. MUHAMMAD TALAAT ELSAYED BADR EL DEEN
He has worked in ministry of health and population as governmental inspector for health care institutions since 2017. Dr. Mohamed worked in Baheya institute for breast cancer as the procurement director . Also, he worked in many hospitals as El Hekma , El Salam international hospital as well as some outpatient pharmacies .
He’s from the board that governs the use of the scientific treatment protocol for COVID -19 MOHP.
Also participated in the tender with UPA for the governmental sector concerned with medical supplies, pharmaceutical products in health care industry.
- Graduated from faculty of pharmacy, Cairo University 2012 .
- Harvard leadership development program certified.
- ISCEA training diploma for CSCA , ongoing CSCM.
- USAID program certified, also syreon research institute Health economics & Pharmacoeconomics diploma .
- Decision making & strategic planning diploma from Nasr academy.
- Critical appraisal and full economic Analysis certificate from GLSBOR .
- Riti’s institute supply chain management diploma.
DR. MUHAMMAD TALAAT ELSAYED BADR EL DEEN
Member of GLSBOR
MR. PRAFUL MEHTA
He has nearly two decades of experience working across the healthcare ecosystem. Prior to Vamstar, Praful was a Senior Partner for IHS Markit and developed healthcare industry’s data and market access capability.
Throughout his career, he has developed solutions pertaining to market access, procurement, pricing and reimbursement, supply chain, and tendering of pharmaceuticals, medical devices, and diagnostics.
Mr. Praful has been a long-time advisor to senior teams across the ecosystem on issues of market access strategies, procurement excellence, launch planning, market competitiveness, and commercialisation strategies. He has significant project experience in working with the BRIC-MT, MENA, APAC, and EU-30 nations, as well as the United States and Japan.
Mr. Praful has been interviewed and quoted in many different journals, print media, blogs, and leadership forums during the two-decades long tenure.
MR. PRAFUL MEHTA
CEO & Co-founder at Vamstar
MR. JOHN MIKHAIL
Mr. John Mikhail, has more than 20 years’ experience in the pharmaceutical industry working in MSD across different commercial functions in Egypt and GCC (sales, marketing, Key Account manager, Tender manager) Also, across various therapy areas including Oncology, Hospital Acute Care, Diabetes, Vaccines and Primary Care.
John’s focus on Strategic Pricing across Gulf started in 2013 where he witnessed the evolving pricing dynamics in GCC starting from GCC price unification implementation throughout the evolving International Price Referencing ending with the new pricing guidelines in Kuwait recently in early 2021.
John’s strong analytical skills can address complex pricing challenges and identify Pricing opportunities.
John’s effective communication skills helped him in multiple negotiations with different
stakeholders across the Gulf.
MR. JOHN MIKHAIL
Strategic Pricing and Tender Lead – GCC at MSD
MR. YASSER HOSNY
Dr. Yasser Hosny, Senior Manager Market Access at Gulf Pharmaceutical Industries Manufacturers Julphar, has more than 28 years of an extensive experience in market access, tender management, and business development in the Middle East, Africa, Europe, and Asia regions. before joining Julphar in 2020, he was responsible for Market access, tender management, and health economics for the EMEA region at Johnson and Johnson diabetes care companies for more than 5 years.
MR. YASSER HOSNY
Senior Manager, Market Access – GCC At Julphar
MR. MOHAMED AMIN
M Amin has more than 25 years of experience in the pharmaceutical industry; Started his career in BMS, Then Joined Astrazeneca in 2008 as Sales Manager in Oncology & CNS Business Unit, then appointed as Head of Market Access in 2014, and currently holding the role of Director of Governmental Affairs, Market Access for advocating AstraZeneca the government partnership agenda and impact in Egypt Healthcare ecosystem.
He has several publications in prominent Health economics Journals and has been an invited speaker in many workshops and panel discussions in Health economics and Health Policy.
M Amin serves in Egypt PHRMA Group as the lead for access to innovation working group
He holds a Health Economic diploma & several professional certificates in Health economics & Outcome research from different international reputable entities
MR. MOHAMED AMIN
Director of Market Access, Governmental Affairs & Regulatory AstraZeneca Egypt
DR. KAREEM NEGM
I am seasoned professional with 16 years of experience working in multinational companies across various functions. I am graduated from Cairo University’s Pharmacy College and have since built a career around market access and helping authorities find innovative, sustainable solutions to increase medication accessibility for patients.
I have furthered your education by earning a certificate degree in Healthcare Economics from Harvard University and are currently pursuing a master’s in public health.
Through your work and studies, I have demonstrated a deep commitment to improving the health outcomes of communities in my region. My passion for this work is evident in everything I do, and I am constantly seeking new ways to innovate and make a positive impact on people’s lives.
DR. KAREEM NEGM
Market Access Manager at Novartis Oncology
TAHA ALAKSHAR
Director - Tender Excellence in the Pharmaceuticals Industry
MR. ISSAM TOUMA SAWAYA
Senior-level executive with 20+ years of Middle East experience. Maximizes results by leveraging multi-channel effective communication, setting and implementing best strategies and tactics practices, remaining receptive to change and the ideas of others, and introducing new offerings and innovations to new and presently existing processes, while bringing passion to purpose and people. Consistently delivers successful outcomes during times of crisis or uncertainty, within the most challenging environments.
Serves as a trusted advisor and confidante to peers, executives, organizational partners, and multi-cultural and multidisciplinary teams. Inspires the identification of hidden opportunities and the development of innovative solutions by collaborating with key stakeholders. Leads through honesty, integrity, and teamwork.
MR. ISSAM TOUMA SAWAYA
Executive Director at PRECISION for Consultancy & Project Development
DR. SARA AL DALLAL
Dr. Sara Al Dallal, the president of the Emirates Medical Association’s Emirates health Economics Society and a specialist in Dubai Health Authority. Dr Sara is a Medical Doctor graduated from the UAE University College of Medicine and Health Sciences. She completed her internal medicine residency in Dubai Health Authority and holds a Masters in Health Care Management from Royal Colleges of Surgeons Ireland and Masters in Health Economics and policy from London School of Economics.
DR. SARA AL DALLAL
Specialist, Health Policies & Strategies Section in the Strategy and Governance Department at Dubai Health Authority
MS. MAYA CHEHAYEB
Ms. Maya Chehayeb works in pharmaceutical industry for more than 20 years where she gained a wide experience by assuming different roles and responsibilities.
She currently holds the position of Commercial Excellence Lead at Biologix FZCO, leading and overseeing company centralized operations in the Middle East & North Africa while heading 3 entities.
Those operations include but are not limited to demand planning, tender management, sales performance assessment, financial reconciliation support, FOC & expired goods management, pricing operations, sub-distributors governance, market mapping database & analytics, Sales & Marketing effectiveness & other projects.
She is responsible for setting & executing strategies and programs to increase efficiency in operations and to minimize risks’ implications.
Maya has joined the Company in 2003 and started her career as medical representative in the Sales department and then was promoted to Senior Brand Manager & Senior Group Brand Manager heading Marketing for a wide range of products. She has as well a solid experience in multichannel communications including events management, promotion & advertising and digital marketing implementation.
She succeeded in developing a set of processes & tools at different levels to optimize cross-functional integration in different operations. She is also a certified internal trainer, and she worked hard through her career to prepare many workshops supporting in skills and capability building.
She holds a Master in Biochemistry from the Lebanese University- Faculty of Sciences. She is also talented in painting and enjoys cooking.
MS. MAYA CHEHAYEB
Commercial Excellence Lead, Middle East & North Africa at Biologix FZCO
DR. SHEREEN ABDALLA
Shereen Abdalla is a seasoned professional in the innovative pharmaceutical industry with over 15 years of experience in sales, marketing, market access & government affairs in the Middle East region. Currently, she serves as the Director of Communications, Government Affairs, and Market Access at GSK for the Gulf Region.
Shereen holds a bachelor’s degree in Pharmaceutical Science from Al Israa Jordan University and Master’s degrees in Health Economics and Pharmacoeconomics from Barcelona University. Her areas of focus include access to innovative medicines and vaccines, health economics, value-based healthcare systems, and healthcare policies.
Throughout her career, Shereen has been dedicated to advancing healthcare in the Gulf region and ensuring that patients have access to the latest treatments and vaccines. With her extensive knowledge and experience in the pharmaceutical industry, she has been instrumental in promoting healthcare initiatives and shaping healthcare policies in the region.
As the Director of Communications, Government Affairs, and Market Access at GSK, Shereen is committed to working with government authorities, healthcare organizations, and other stakeholders to improve access to innovative medicines and vaccines in the Gulf Region.
With her passion for improving healthcare outcomes and her strong commitment to her work, Shereen is poised to make a lasting impact on the health and well-being of people in the Gulf region.
DR. SHEREEN ABDALLA
Director of Communications, Government Affairs, and Market Access at GSK - Gulf Region
DR HUSAM MAJALI
- Medical degree from University of Jordan.
- Gynecology Specialty Board from Jordan Medical
- Master of Health Economics from Barcelona school of management.
- Master of Clinical Science from Western University in Canada.
- Currently working with MSD pharmaceuticals as HTA & Insurance Lead in the Gulf, with the role of strengthening the partnership relationships between MSD and private health insurance companies.
DR HUSAM MAJALI
Market Access Lead- HTA & Insurance Gulf at MSD
DR. FATIMA ZAID ABU ZANAT
Dr. Fatima Zaid Abu Zanat is an aspirational and experienced Regulatory Affairs/Quality Assurance (RA/ QA) professional with total of 17 years’ experience, with more than 12 RA/QA years in medical device, pharmaceutical and biotech industry across emerging markets with solid scientific background in product research/ development. She holds RAPS Dual Regulatory Affairs Diploma and Certificate (RAC Dual) in Medical Devices/Pharmaceuticals in addition to MSc in Pharmaceutical Technology. She is an active member in regulatory working groups within regulatory associations such as RAPS MENA local networking group as well as industry associations such as PhRMA MEA and formerly MECOMED. She is a licensed Basic Life Support Giver by American Heart Association and Licensed Specialist Pharmacist by UAE Ministry of Health and Jordan Food and Drug Administration.
She successfully established and managed multiple, UAE Scientific Offices for regional headquarters of emerging markets within Dubai, UAE; enabling organic/in-organic business growth. She built strong, direct channels with key, regional health authorities for continuous, shaping of the industry. She is experienced with development and management of teams on regional/global levels.
International publications:
- RAPS E-BOOK: F.Z. ABU– ZANAT(2022). Section IV postauthorization commitments and studies: Chapter 18 Middle East and North Africa. In L.M. and P.T (Ed.). Postapproval Changes for Drugs: A Practical Guide (pp. 209 – 212). RAPS.
- RP– LC Analysis Article: F.Z. ABU– ZANAT(2012). Ibuprofen Determination in Aqueous Solutions and Biological Samples. MedLab Magazine, 2012 (1): 36 – 42.
- Research Article: F.Z. ABU– ZANAT et al(2011). A Promising Codrug of Nicotinic Acid and Ibuprofen for Managing Dyslipidemia. I: Synthesis and In Vitro Evaluation. Drug Development and Industrial Pharmacy, 37 (9): 1090 – 1099.
Honors and awards:
- Women of Ipsen Nomination – 2022: One of 68 nominated Women of Ipsen for 2022 and the only one from META region.
- DUPHAT 2012 – 3rd Best Professional Poster Award: Professional Poster and Oral Presentation entitled “Synthesis and Evaluation of Nicotinic Acid and Ibuprofen Codrug for Managing Dyslipidemia by Newly Developed and Validated HPLC Method”, based on MSc Pharmaceutical Technology thesis dissertation.
DR. FATIMA ZAID ABU ZANAT
Regional Director of Regulatory Affairs & Scientific Office Middle East, Turkey & Africa at Ipsen Pharma
MR. NICO BACHARIDIS
Nico has spent over 13 years in the pharmaceutical industry in local, regional and global roles. He has built and led the global team at Pfizer responsible for the management of the worldwide Tender & Contracting business and the continuous improvement of tender processes, tools, capabilities and policies. During this time he was also part of Pfizer’s global x-functional leadership team for Biosimilars. Nico is one of the few people who have personally built and lead a truly global and x-functionally aligned tender organization in big pharma.
MR. NICO BACHARIDIS
Chief Commercial Officer of CubeRM
MEET OUR PREVIOUS SPEAKERS
Anouar Ben Younes
Anouar is Regional Market Access & Government Affairs Director for AbbVie Biopharmaceutical
for the Middle East & Africa Region. He has joined AbbVie in January 2014.
Anouar began his career in 2001 as Medical Representative then progressed through positions
of increasing responsibility in Sales, Marketing, Market Access and General Management in
Schering Plough, Novo Nordisk and MSD at affiliate and region levels before joining Abbvie as
Regional Market Access Director, Middle East & Africa.
Anouar carries a Medical Diploma from Faculty of Medicine of Tunis, Executive Business Studies
Diploma (MBA-like) from ALBA business school (Greece) and European Market Access Diploma
from University of Lyon (France).
Acting as leader of PhRMA MEA “Value & Pricing” working group & “Tendering & Contracting”
workstream and member of PhRMA MEA “IP” & Oncology” working groups.
Anouar Ben Younes
Regional Market Access & Government Affairs Director Middle East & Africa at AbbVie
Asmaa Kalil
Asmaa Khalil is manager of MENA RA at Boston Biopharma. She has more than 15 years’ experience in global regulatory affairs “MENA Region, African Countries, CIS Region, APAC region & EU region”. Asmaa is expert consultant in CTD, NeeS & eCTD compilation and submission/publishing of dossier. She was the speaker of more than 30 workshops in Egypt & GCC for regulatory affairs and CTD/eCTD sessions. Asmaa has global network contacts with agents and support pharmaceutical companies to start building new export business worldwide. Asmaa earned her B.S. in Pharmaceutical Sciences from Cairo University, and her M.Sc. in Biochemistry
Asmaa Kalil
MENA RA Manager @ Boston BioPharma -Egypt
Bashar Kayali
Bashar Kayali is a Pharmacist with MBA Degree with more than 18 years in the Pharmaceutical & Healthcare business. He has experienced different roles throughout the industry from Brand Manager at Roche to sales manager in Sandoz.
Currently he is the tenders & market access manager in Octapharma, a Swiss Multinational manufacturer, for blood & plasma products to supply hemophilia patients with novel medicines.
Bashar Kayali
Sales and Tender Manager, Octapharma Plaza, Inc.
Dr. Abdalla Abotaleb
Dr. Abdalla Abotalleb is one of the most profound experts in healthcare policy and regulations in the Middle East. His expertise extends from HTA & Reimbursement policies to regulatory and supply chain strategies in the public sector. He has been involved in the fields of health economics, outcomes research, and reimbursement policy within the healthcare industry for 15 years, with experience across the pharmaceutical, biologicals and vaccines. And now works for WHO as a project manager at health care reforming area. Abdalla Abotaleb graduated in faculty of pharmacy then obtained a post-graduate in health economics followed by a PhD in Health Economics & Policy form York University. He also has a degree in Project management professional (PMP), Pharm. D certificate and a Master of business administration (MBA). He, in addition to being a committee member and project manager in several national projects in many countries including Germany. United Kingdom, Egypt, Algeria, Sudan, Russia, and Poland, He is a very active researcher with tens of publication across different well recognized organizing including ISPOR, ESMO, ASCO, ECCO, iHEA. HTAI, and EAHE. He has been a true contributor to several public and industrial projects in Egypt, his homeland. He committedly changed the landscape of the healthcare policy there. A few examples to mention are his contributions to the establishment of the NORCB (national organization for control and research of biologics), Egyptian Biosimilars guidelines the cancer and MS registry. Establishing stroke units, hospital based HTA and Health economic unit at ministry of health in Egypt’s different sectors. Multiple engagement efforts are well recognized in his research through introducing concepts of stakeholder engagement. He also does that by being an active member of many research organizations internationally and locally like the ISPOR. Abdalla Abotalleb remains a very rich source of developmental initiatives having been hands on expert across different sectors of the healthcare systems and a visionary for healthcare reform.
Dr. Abdalla Abotaleb
Project Manager at World Health Organization (WHO
Dr. Mohamed Amin
Mohamed Amin has more than 25 years of experience in various fields of the pharmaceutical industry, including Sales, Market Access, patient Support, Tender & supply chain work almost with all therapeutic areas specially oncology Holding Health Economic Diploma.
Holding health economic certificate from World bank received several awards and recognitions at both local and above-market levels in market access.
He has many publications in ISPOR Europe conference, and in some international magazines concerned with health economics managed many tenders, and facilitate patient accessibility to innovative medicine
Dr. Mohamed Amin
Director of Market Access , KAM, Tender , Regulatory and government Affairs at AstraZeneca
Dr. Mubarak Hassan Abdulla
He is a Director of Purchasing and Contracts Department (Supervision of tenders & involve in finalizing & tenders committee) in EHS Emirates Health Services. He has an experience in Auditing & giving Lectures
With a PhD. in Banking Transactions from 10 years and Master in Executive Master of Business Administration (EMBA) from Sharjah University
He has some Professional Certificates & Training like: Leadership, Innovation, and strategy, GE Company. The 7 Habits of Highly Effective People, Franklin Covey – Middle East. Mini MBA for Supply Chain Professionals, Purchasing & Procurement Center. Mini MBA for Procurement Professionals, Purchasing & Procurement Center
Trained workshops in some related fields such as: Financial Transactions, Contracts for Financing and Financing applications in Banks, Government Accountancy for Non-Accountants.. etc
Dr. Mubarak Hassan Abdulla
Director of Purchasing and Contracts Department, EHS, UAE
Dr. Sherif Hammad
Dr. Sherif Hammad is a self-motivated, value driven professional that started his own Tender and Market Access Consultancy for local and International clients in the UAE.
He has expertise in market access, tender management, sales, marketing, field sales management and in both strategic and operational pricing.
With extensive years of experience in the pharmaceutical industry, his career journey included several Global organizations working on different therapeutic areas.
Dr. Sherif has a Bachelor of Science (B. Sc. Vet. Medicine) from Cairo University, Professional Diploma in Marketing from the Chartered Institute of marketing, UK, received his: Specialized certificate of pharmaceutical marketing research in 2012, a “Pricing Strategy Optimization Specialization Certificate” from the University of Virginia, USA and Health Technology Assessment Fellowship at HTA office & Wifor institute in Germany. To top this he is a certified as a trainer in his field.
Dr. Sherif Hammad
Market Access, Tender Management, Strategic, Operational Pricing and Marketing Consultant Freelancer
Eduardo Valencia
Dedicated Data Analyst and Data Scientist. Specialized in predictive algorithms for tendering in the pharmaceutical industry. Author and speaker.
Eduardo Valencia
Data Analytics Manager at Konplik
Dr. Feras Al Tarifi
Dr. Feras Al Tarifi earned his BSC. Pharmacy at the University of Jordan in 1997 and Pharmacy Practice & Clinical Pharmacy at Creighton University – Nebraska, USA and have honed is career ever since building his professional community through being on Comities and Boards and working for top International Pharmaceutical Companies.
He started in Abbot EPD /Solvay Pharmaceuticals as a Medical Rep and quickly climbed the ranks to Marketing Manager before he moved over to Hikma Pharmaceuticals as Brand Manager in RA and Tender Management and Business Intelligence. He advanced to Hangzhou Huisheng Biotech Pharm, then PIZHOU FUTONG BIOCHEMICALS and now he is the Central Tender and Strategic Business Development Director of Al Taqaddom Pharmaceutical Industries (TQ Pharma)
He serves on the Faculty of Pharmacy Board – Yarmouk University (Governmental) since 2020 and is a member of the Faculty of Pharmacy Alumni Committee – The University of Jordan and has received several recognized achievements by the Faculty of Pharmacy – Jordan University of Science & Technology (Governmental), The Jordanian Hashemite Fund for Human Development – JoHUD (headed by HH Princess Basma Bint Talal), Scientific Committee of JPA – Central, Zarqa, Irbid Governate JPA and the Belgian Embassy as being part of the best Belgian company working in Jordan for 2005 with Abbott.
He is a father or 3 busy boys Sanad, Basel & Saif.
Dr. Feras Al Tarifi
Strategic Business Development Director & Central Tender Business Director TQ Pharma, Jordan
Dr. Feras A. Boursan
Feras Boursan is the business development manager for Boston Biopharma, a pharmaceutical company focused on development and
manufacturing Oncology products. In this role I lead the company’s B2B efforts and find out a new opportunities.
Experience
Boston Biopharma
Director Of Business Development
January 2013 – Present (8 years 6 months)
EMEA
Responsible for :
-In/Out-Licensing
-Joint Venture
-New Products
ASIA Pharmaceutical
Product Marketing Manager
February 2011 – 2013 (2 years)
Pharmacode
International Business
2011 – 2012 (1 year)
HZM Pharma
Group Product Manager
2005 – 2010 (5 years)
GAIA PHARMA
Export Business development
2003 – 2005 (2 years)
Pharmacode
Export Manage
Dr. Feras A. Boursan
Business Development manager for Boston Biopharma
Dr. Firas W. Al-Shawish
Firas Al Shawish, Pharmacist with more than 20 years’ experience in pharmaceutical field, an enthusiastic and a dedicated business manager with an experience and a diversify experience in pharmaceutical industry in managing commercial sales and marketing as well as logistics and order handling.
In 2000 earned my B.Sc. degree in Pharmacy from Applied Science University (faculty of pharmacy) and in 2010 made my MBA degree from Amman Arab University for Graduate studies.
My footpath started as a medical representative presenting medicines to different HCP and escalate in my career path to become Regional Tender Manager for one of the biggest pharmaceutical companies in the world “MSD”.
“The key to success is to focus on goals, not obstacles.”
Dr. Firas W. Al-Shawish
Regional Tender Manager, Marketing Operation/Alliance - LEVANT Cluster
MSD-Jordan
Jose Luis Martinez
José Luis is passionate about applying state of the art artificial intelligence technology to improve healthcare and pharma processes. From EHR analysis to identify relevant records by labeling diseases, treatments, diagnosis and so on; to pricing analytics for drugs. Artificial Intelligence, Natural Language Processing, semantic technology, deep learning, cognitive computing, machine learning, clustering, classification, Big data, … a lot of technologies to uncover insights from structured and unstructured data.
José Luis holds a PhD in Telecommunications at the Technical University of Madrid, and an Executive MBA from the IE Business School.
Jose Luis Martinez
CEO at Konplik
Khalid Ibrahim
Institution and Tender Manager, Bayer Pharmaceuticals - GULF
Lora Fleifel
Lora Fleifel is the Regional market access and pricing director for Middle East, Africa, Turkey and Russia at Merck Healthcare.
On top of her experience in pharmaceutical sales & project management roles, Lora has a decade of extensive market access and pricing expertise at Sanofi and Merck, on local, regional, and global assignment levels across multiple complex healthcare markets.
She is a licensed pharm D pharmacist, with a masters’ degree in health economics and pharmacoeconomics to hone her market access understanding at a time when this was still a relatively undeveloped function in the region, convinced of the value this role could bring to her personal aspiration of improving health and medical services in the region.
As a universal citizen with a multicultural Lebanese, Belgian nationality, and a believer in the power of “As one for Patients”, she aspires to bring Europe and Middle East closer together in terms of culture, and healthcare standards.
Lora Fleifel
Market Access and Pricing Operations Director, Merck
Matthew Eddletston
Commercial Director Celltrion Healthcare UK. Vice Chair British Biosimilars Association (BBA)
Maya M. Chehayeb
Maya Chehayeb works in pharmaceutical industry for more than 18 years where she gained a wide experience by assuming different roles.
She currently holds the position of Commercial Excellence Lead at Biologix Fzco responsible to ensure operational excellence for the overall company portfolio in Middle East & North Africa. She is managing sales & operations planning in terms of demand planning, tender management, financial performance assessment and reconciliations with local distributors. She also oversees sales & marketing effectiveness of the company.
Maya started her career in 2003 as Medical Representative in sales department of Algorithm SAL and then was promoted to Senior Brand Manager & Senior Group Brand Manager heading Marketing for wide range of products. She then moved as Human Health Support Lead to manage customer operations, multichannel communications including events management, promotion & advertising as well as digital marketing implementation.
She succeeded in developing a set of processes & templates at different levels to optimize cross-functional integration. She is also a certified internal trainer and she worked hard through her career to prepare many workshops to support the company in building skills for many colleagues.
She has a Master in Biochemistry from Lebanese University- Faculty of Sciences. She is also talented is painting and enjoys cooking.
Maya M. Chehayeb
COMMERCIAL EXCELLENCE LEAD AT BIOLOGIX FZCO- MENA REGION
Mazen Abdul Majid
Dr. Mazen Abdul Majid is currently leading Market Access operations at Hikma pharmaceuticals in UAE
Mazen brings a mix of different senior roles through his 17 years of pharmaceuticals business experience within Tender business, Sales and Brand management at Multinational companies.
Certified as Doctor in dental surgery and currently running an MBA program from Abu Dhabi university
Mazen Abdul Majid
Market Access Lead, Tenders & Key Account Management, Hikma, UAE
Mazen Boughanem
Quality Director-MENA at Bausch Health
Mohamed Ibrahim
Head of regulatory affairs in Batterjee Pharma, Batterjee Pharma is a local Saudi pharmaceuticals and cosmoceuticals manufacturer, Mohamed is managing regulatory submissions in Saudi Arabia, GCC market and exports business development.
Mohamed is also interested in corporate strategies and people empowerment.
Mohamed Ibrahim
Regulatory Affairs Section Head Batterjee Pharma, KSA
Murtadha Al Sanjari
Head of Operations, Nasma Co. for Storage and General Trading, Iraq
Nico Bacharidis
Nico is the founder of Growpal, a Switzerland-based consulting company and healthcare ecosystem builder. As the former global Tender & Contracting Lead of Pfizer, he is one of the few people who have built up and lead a tender & contracting organization for a global pharmaceutical company. He has a unique know-how and experience in tender & contracting capabilities, processes, policies, teams & tools.
Nico Bacharidis
Founder & CEO, Growpal, Switserland
Rania Kassab
A Strategic commercial leader with an experience more than 15 years in multiple commercial functions across several regions, from Medical Rep in 2004, Trade and Tender, CNS Commercial Manager – Gulf, Brand Category Manager, DERMA – Gulf, Global Market Access Manager – UK to becoming the Business Effectiveness and Operations Manager – UAE.
Rania serves as Lead in the Women Leadership Initiative and holds an MBA from SBS Swiss Business School and a Degree in Pharmacy from Jâmi’at Bâyrut Al-Arabiya, Lebanon.
Rania Kassab
Business Effectiveness and Operations Manager
Reyhan Sarioglu
Business Development Manager, Audubon Bioscience Istanbul, Turkey
Sheryl Sidharth Dhas
Sheryl Sidharth Dhas is an experienced tender professional having 12years experience in the Middle East Healthcare sector after handling tenders in the oil & gas arena for 5 years.
She has held positions of increasing responsibility during her stints with different companies and has formulated the standards and guidelines for their participation in tenders. She has helped evaluate and design tools to enable the determination of optimum offer prices and the tracking of tender performance from submission to delivery.
She is a skilled project manager and is goal-oriented, proactive and optimistic by nature.
Sheryl has a Bachelor’s in Management Studies and Master’s in Business Administration with a specialization in Marketing.
Sheryl Sidharth Dhas
Regional Tender Manager Middle East
Sumaya Al-Janabi
Sumaya is a pharmacist who is passionate in helping the growth of pharmaceutical industry in her home country, Iraq.
Driven by her ambition in delivering the most innovative products to the Iraqi patients, she always put the right plan for pharmaceutical companies, to secure the access and availability of their drugs. With a bachelor’s degree in Pharmacy and over 13 years of experience in the pharmaceuticals field, Sumaya has mastered an outstanding skill in dealing with MoH tenders, Sales, Marketing, Market Research, Competitive Intelligence, and Market Access.
When she is not working, you will find Sumaya swaying to the tunes of Salsa music, cooking Iraqi food, or just chilling with her friends and watching Netflix.
Sumaya Al-Janabi
Head of Tenders and Market Access, Global Head
Powered By
Organized By
We accept
